EPSO publishes a first reaction to the Court of Justice of the EU ruling regarding mutagenesis and the GMO Directive in which European Plant Scientists express their disappointment on the ruling which classifies plants obtained by recent techniques such as CRISPR-Cas9-mediated genome editing as GMO that are subject to extensive pre-market risk evaluations. It is contrary to scientific evidence and as it stands now, it very likely will prevent the use in Europe of such technologies to address food and nutritional security and a more positive impact of agriculture on the environment. EPSO offers to collaborate with policy makers to develop an appropriate regulation addressing the issue of how a product of NBTs differs from those achieved with other breeding approaches to balance potential benefits and risks. See brief statements from EPSO members and partners on the ECJ ruling regarding mutagenesis and GMO Directive.
- The European Commission published the third countries participation anticipated for Horizon Europe, incl. e.g. Israel, Norway, Serbia, Ukraine and UK. Swiss project partners will be funded by Switzerland 13/07/2021
- ISE position on Horizon Europe identifies three areas of intervention: Interdisciplinarity, Widening participation, Balancing Research and Innovation Actions 12/07/2021
- PBE 2021 – The Plant Biology Europe joint conference of EPSO and FESPB will start on Monday 28 June and offer an exciting programme until 1 July. 25/06/2021